Results 11 to 20 of about 4,765 (162)
Therapeutic Potential of Dronabinol: A Systematic Review of Human Trials [PDF]
Farmacja Polska, 2021 Dronabinol is an isomer of tetrahydrocannabinol that seems to have potential for both somatic and psychiatric disorders treatment. The purpose of this review is to provide an overview of collected articles with emphasis on the efficacy and safety of ...
Julia Lewandowska +2 more
doaj +1 more source
Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Medical Cannabis and Cannabinoids, 2023 Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome.
Edward Y. Liu +2 more
doaj +1 more source
DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats
Journal of Cannabis Research, 2023 Introduction Dimethyl sulfoxide (DMSO) is an amphipathic molecule with innate biological activity that also is used to dissolve both polar and nonpolar compounds in preclinical and clinical studies.
Michael W. Calik, David W. Carley
doaj +1 more source
Palliative Medicine Reports, 2023 Background: Cannabis may offer therapeutic benefits to patients with advanced cancer not responding adequately to conventional palliative treatment. However, tolerability is a major concern.
Ditte Buchwald +8 more
doaj +1 more source
Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury
Trauma Surgery & Acute Care Open, 2020 Background To determine whether adjunctive dronabinol, a licensed form of delta-9-tetrahydrocannabinol, reduces opioid consumption when used off-label for managing acute pain following traumatic injury.Methods This matched cohort study included patients ...
Kristin Salottolo +5 more
doaj +1 more source
Brain Sciences, 2020 Delta-9-tetrahydrocannabinol (Δ9-THC) and other cannabinoids present in cannabis (marijuana) have been shown to affect the normal inhibitory pathways that influence nociception in humans.
Claire Swartwood +3 more
doaj +1 more source
Caracterización de la problemática del uso terapéutico del Aceite de Cannabis en Córdoba, Argentina
Revista de la Facultad de Ciencias Médicas de Córdoba, 2022 El uso terapéutico del aceite de “cannabis” es una problemática social que pone en tensión aspectos legales, sanitarios, científicos y culturales. La dificultad en el acceso genera un vacío aprovechado por el mercado ilegal, al que recurren pacientes y ...
Pablo Gabriel Manzo +9 more
doaj +1 more source
Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. [PDF]
PLoS ONE, 2014 The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis.
Michael W Calik, David W Carley
doaj +1 more source
Acetylcholinesterase Inhibitory Activity of Standardized Cannabinoids-rich Fractions [PDF]
Pharmaceutical and Biomedical Research, 2023 Background: Since cannabis has been legally allowed for medicinal purposes in many countries, it has become the most interesting issue, particularly in neurologic disorders, such as Alzheimer’s disease (AD).
Wiwit Suttithumsatid +4 more
doaj
Unexpected improvement of hyperhidrosis with cannabidiol [PDF]
Einstein (São Paulo), 2022 Hyperhidrosis is characterized by excessive sweating and it affects almost 5% of the population. The affected age group is wide, and it can affect from children to elderlies. There are two types of hyperhidrosis: generalized and focal.
Rubens Pitliuk +2 more
doaj +1 more source